| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/02/1995 | CA2170357A1 Method for producing a highly enriched population of hematopoietic stem cells |
| 03/02/1995 | CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy |
| 03/02/1995 | CA2169849A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/01/1995 | EP0640350A2 Ceramic particles and their preparation |
| 03/01/1995 | EP0640143A1 Senescent cell derived inhibitors of dna synthesis |
| 03/01/1995 | EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/23/1995 | WO1995005201A1 Adenoviruses having modified fiber proteins |
| 02/22/1995 | EP0319570B1 Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1994023028A3 Modified oligonucleotides having improved anti-influenza activity |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/15/1995 | EP0638119A1 Chimeric receptor genes and cells transformed therewith |
| 02/15/1995 | EP0637965A1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 02/14/1995 | US5389514 Transfection; hybridization; converting uridine to cytidine by means of nuclear extract obtained from human or mammal or flies cells |
| 02/14/1995 | US5389069 Method and apparatus for in vivo electroporation of remote cells and tissue |
| 02/09/1995 | WO1995003834A1 PRE-BINDING OF RETROVIRAL VECTOR PARTICLES WITH COMPLEMENT COMPONENTS TO ENABLE THE PERFORMANCE OF HUMAN GENE THERAPY $i(IN VIVO) |
| 02/09/1995 | WO1995003832A1 Intracellular immunization |
| 02/09/1995 | WO1995003788A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168243A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/07/1995 | US5387520 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003407A2 Oligonucleotides with activity against human immunodeficiency virus |
| 02/02/1995 | WO1995003406A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003318A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | WO1995003083A1 Drug delivery |
| 02/02/1995 | WO1994029442A3 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 02/02/1995 | CA2168232A1 Recombinant c140 receptor and its agonists and antagonists |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166890A1 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 01/26/1995 | WO1995002697A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/26/1995 | WO1995002687A1 Immortalized human fetal osteoblastic cells |
| 01/26/1995 | WO1995002420A2 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | WO1995002413A1 Suppression of inhibitors |
| 01/26/1995 | WO1995002397A1 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 01/26/1995 | CA2167153A1 Prodrugs of protein tyrosine kinase inhibitors |
| 01/26/1995 | CA2144040A1 Defective adenovirus vectors and use thereof in gene therapy |
| 01/25/1995 | EP0635068A1 Amplification of human mdm2 gene in human tumors |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0634896A1 Evaluation and treatment of patients with progressive immunosuppression |
| 01/19/1995 | WO1995002069A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | WO1995002065A1 Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| 01/19/1995 | WO1995002057A1 Protein tyrosine kinase and ligands thereof |
| 01/19/1995 | WO1995002038A1 Yolk sac stem cells and their uses |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1995001801A1 Growth differentiation factor-6 |
| 01/19/1995 | CA2166694A1 Yolk sac stem cells and their uses |
| 01/19/1995 | CA2166058A1 Oligonucleotide modulation of protein kinase c |
| 01/19/1995 | CA2165778A1 Growth differentiation factor-7 |
| 01/19/1995 | CA2165776A1 Growth differentiation factor-6 |
| 01/18/1995 | EP0633943A1 Gene therapy using targeted viral vectors |
| 01/18/1995 | EP0633937A1 Immunization by inoculatioon of dna transcription unit |
| 01/18/1995 | EP0378576B1 Transduced fibroblasts and uses therefor |
| 01/12/1995 | WO1995001447A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001364A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 01/12/1995 | WO1995001095A1 Transformed eukaryotic cells, and transposon-based transformation vectors |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2143620A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/11/1995 | EP0633318A1 Transduced fibroblasts and uses therefor |
| 01/11/1995 | EP0632722A1 A dna transporter system and method of use |
| 01/05/1995 | WO1995000654A1 Mesothelial cell gene therapy |
| 01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
| 01/05/1995 | WO1995000638A2 Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection |
| 01/05/1995 | WO1995000178A1 Pore-forming and superantigen encoding toxin cassettes for gene therapy |
| 01/05/1995 | WO1994023041A3 Method for selective inactivation of viral replication |
| 01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
| 01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631618A1 Culturing of hematopoietic stem cells and their genetic engineering |
| 01/04/1995 | EP0567576B1 Treatment of neoplastic disease with interleukin-10 |
| 01/03/1995 | US5378825 Backbone modified oligonucleotide analogs |
| 12/28/1994 | EP0630409A1 Defective packaging non-oncoviral vectors based on mpmv and hiv |
| 12/28/1994 | EP0630384A1 Methods and compounds for prevention of graft rejection |
| 12/27/1994 | US5376542 Method for producing immortalized cell lines using human papilluma virus genes |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029471A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | WO1994029470A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 12/22/1994 | WO1994029469A2 Plasmids suitable for gene therapy |
| 12/22/1994 | WO1994029468A1 Untranslated exon-1 sequences of eukaryotic genes as promoters |
| 12/22/1994 | WO1994029444A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
| 12/22/1994 | WO1994029442A2 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |